顔面注射市場規模、成長と動向分析レポート 2025-2030年

出版社 Grand View Research
出版年月 2025年3月

Facial Injectable Market Size, Share & Trends Analysis Report

顔面注射市場 : 製品(コラーゲン&PMMAマイクロスフィア、HA)、用途別(顔の輪郭修正、唇の増強)、最終用途別、地域、セグメント別予測による市場規模、成長と動向分析レポート 2025-2030年
Facial Injectable Market Size, Share & Trends Analysis Report By Product (Collagen & PMMA Microspheres, HA), By Application (Facial Line Correction, Lip Augmentation), By End-use, By Region, And Segment Forecasts, 2025 – 2030

The global facial injectable market size is expected to reach USD 24.9 billion by 2030, registering a CAGR of 12.3% from 2025 to 2030, according to a new report by Grand View Research, Inc., The facial injectables are crucial in anti-aging treatments and are particularly used to stop damage such as hyperpigmentation and early aging. The most popular treatments across all socioeconomic groups are Botox and fillers, which have gained immense popularity.

世界の顔面注射市場規模は2030年までに249億米ドルに達し、2025年から2030年にかけて年平均成長率(CAGR)12.3%で成長すると予測されています。顔面注射剤はアンチエイジング治療において極めて重要であり、特に色素沈着や早期老化などのダメージを予防するために使用されています。あらゆる社会経済層で最も人気のある治療法は、ボトックスとフィラーであり、非常に高い人気を誇っています。

顔面注射市場規模、成長と動向分析レポート 2025-2030年
facial-injectable-market

Facial Injectable Market Report Scope

Report Attribute Details
Market size value in 2025 USD 13.9 billion
Revenue forecast in 2030 USD 24.9 billion
Growth rate CAGR of 12.3% from 2025 to 2030
Actual data 2018 – 2024
Forecast period 2025 – 2030
Quantitative units Revenue in USD million/billion, and CAGR from 2025 to 2030
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Product, application, end use, region
Regional scope North America; Europe; Asia Pacific; Latin America; MEA
Country scope U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Sweden; Denmark; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Argentina; Saudi Arabia; South Africa; UAE; Kuwait
Key companies profiled Ispen; Abbvie; Medytox Inc.; Merz GmbH and Co. KGaA; Revance Therapeutics, Inc.; Galderma; Sinclair Pharma
Customization scope Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope